Search

for
Search:

Research

5 / 1000+ results

research A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.

9 citations , November 2021 in “PubMed”

This study found that FDA-approved low-level light/laser therapy devices significantly increased hair density in individuals with pattern hair loss compared to sham devices.

research Photobiomodulation devices for hair regrowth and wound healing: a therapy full of promise but a literature full of confusion

36 citations , April 2016 in “Experimental Dermatology”

This review discusses the challenges in selecting optical parameters for photobiomodulation studies on hair regrowth and wound healing, reporting no new clinical results and recommending more rigorous, standardized research approaches.

research In vivo experimental studies for hair growth: systematic review

January 2022 in “Open MIND”

This review discusses the adverse effects of FDA-approved drugs for hair loss and promotes further research into natural herbal products but reports no new clinical results.

research An Analysis on Whether or Not Baldness Can Be Reversed

January 2017 in “Touro Scholar (Touro College)”

This review concludes that while hair loss cannot be cured, its progression can often be halted or reversed with continuous use of FDA-approved drugs like finasteride and minoxidil.

research Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways

July 2024 in “European Journal of Medicinal Chemistry”

This review discusses the increasing prevalence of alopecia in younger populations and outlines the need for better understanding its pathogenesis to develop effective treatments. It also examines current FDA-approved drugs and emerging small molecule compounds with potential anti-alopecia effects.

View more "fda-approved hair growth drugs" in research →

Community Join

5 / 769 results

community I had claude create a protocol only using fda approved drugs.

4 upvotes 8 months ago

A new hair loss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.

community Jeff Vincent and his stealth drug growth stimulant is on track for Q1 2027

89 upvotes 1 month ago

A new hair growth drug claims to reverse severe hair loss without using minoxidil, finasteride, or hormone-altering drugs, but many are skeptical due to lack of evidence and concerns about misleading claims. The drug is expected to be released in early 2027, but its legitimacy is questioned.

community New baldness drug boosts hair coverage by up to 86% in six months

719 upvotes 3 months ago

A new extended-release oral minoxidil formulation claims to improve hair growth by maintaining steady blood levels, reducing side effects like hypotension, and potentially benefiting female hair loss. However, it is not considered groundbreaking as it builds on existing minoxidil treatments, and its effectiveness compared to current doses is debated.

community Dutasteride would have been approved for AGA by the US FDA.

in Finasteride/Dutasteride 84 upvotes 1 year ago

Dutasteride is more effective than finasteride for hair loss, with some users experiencing fewer side effects. Users share experiences with dutasteride, finasteride, minoxidil, and biotin, discussing dosage and fertility concerns.

community With studies showing that 0.2mg Finasteride is almost as effective as 5mg at reducing DHT, why is every doctor prescribing 1mg?

252 upvotes 10 months ago

Finasteride is prescribed at 1mg because it is FDA-approved and proven effective, despite evidence that 0.2mg may similarly reduce DHT. The 1mg dose is more effective for hair growth, and lower doses are less available.

View more "fda-approved hair growth drugs" in community →

Learn

7 / 21 results

learn Stem Cell Factor

learn Tofacitinib

JAK inhibitor pill, an immune-system drug

learn GHK-Cu

Copper peptide used in skin and hair cosmetics

learn Thymosin Beta 4

What should users understand about the scientific status of Thymosin Beta 4 in hair growth therapies? Thymosin Beta 4 is not an approved treatment for hair loss, and its hair evidence comes only from animal and cell studies. Its grey-market form, TB-500, is flagged by the FDA for safety risks and banned in sport.
How is Thymosin Beta 4 typically incorporated into experimental or advanced hair growth products? Thymosin Beta 4 is not an ingredient in any approved hair-loss product; it is an unapproved research peptide sold online as TB-500, which the FDA flags for safety risks. Hair studies are in rats and mice only, with no human trials, and animal studies link Tβ4 to tumour spread.

learn Platelet-Rich Plasma

Concentrate of your own blood platelets, injected into the scalp

learn Biotin

Vitamins vs. minoxidil: who wins the battle for hair growth? Topical minoxidil is approved for pattern hair loss and has trial evidence; reviews find that reported benefits of vitamins such as biotin come mainly from people with a deficiency. The FDA warns that biotin supplements can make some blood tests give wrong results.

learn Bimatoprost

Can a lash-growth serum like bimatoprost actually work for your scalp? Bimatoprost (Latisse) is FDA-approved only for eyelashes, not the scalp. In the larger of two Allergan phase 2 scalp trials, every bimatoprost formulation gave smaller hair-count gains than minoxidil 5%; the results were posted to ClinicalTrials.gov but never published in a journal, and scalp use remains off-label and experimental.
How does bimatoprost compare to minoxidil for hair regrowth? Minoxidil is FDA-approved for scalp hair loss and backed by decades of large trials; bimatoprost is approved only for eyelashes, and the published scalp evidence is limited to small short studies, so on the scalp it is off-label and experimental.

View more "fda-approved hair growth drugs" in learn →

Clinics

2 / 5 results

Experts

1 / 5 results

SMP Specialist
Hairo Fallas
Newark, NJ, United States

Hairo Fallas